X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS DISHMAN PHARMA DR. DATSONS LABS/
DISHMAN PHARMA
 
P/E (TTM) x -10.9 25.1 - View Chart
P/BV x 0.2 3.3 4.9% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 DR. DATSONS LABS   DISHMAN PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
DISHMAN PHARMA
Mar-16
DR. DATSONS LABS/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs126374 33.5%   
Low Rs31129 24.0%   
Sales per share (Unadj.) Rs133.0197.8 67.2%  
Earnings per share (Unadj.) Rs0.221.2 0.7%  
Cash flow per share (Unadj.) Rs6.634.7 19.0%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8179.9 71.6%  
Shares outstanding (eoy) m31.6680.69 39.2%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.61.3 46.2%   
Avg P/E ratio x516.111.9 4,349.2%  
P/CF ratio (eoy) x11.87.2 163.4%  
Price / Book Value ratio x0.61.4 43.4%  
Dividend payout %09.4 0.0%   
Avg Mkt Cap Rs m2,47720,306 12.2%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m565,355 1.0%   
Avg. sales/employee Rs ThNM19,252.7-  
Avg. wages/employee Rs ThNM6,459.5-  
Avg. net profit/employee Rs ThNM2,064.1-  
INCOME DATA
Net Sales Rs m4,21115,961 26.4%  
Other income Rs m79265 29.7%   
Total revenues Rs m4,28916,226 26.4%   
Gross profit Rs m5694,103 13.9%  
Depreciation Rs m2041,091 18.7%   
Interest Rs m430944 45.6%   
Profit before tax Rs m132,334 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-21 -163.6%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6624 1.0%   
Profit after tax Rs m51,711 0.3%  
Gross profit margin %13.525.7 52.5%  
Effective tax rate %48.026.7 179.7%   
Net profit margin %0.110.7 1.1%  
BALANCE SHEET DATA
Current assets Rs m6,85211,018 62.2%   
Current liabilities Rs m6,7119,517 70.5%   
Net working cap to sales %3.39.4 35.6%  
Current ratio x1.01.2 88.2%  
Inventory Days Days161110 145.6%  
Debtors Days Days31835 914.2%  
Net fixed assets Rs m3,67316,304 22.5%   
Share capital Rs m317161 196.2%   
"Free" reserves Rs m3,76112,907 29.1%   
Net worth Rs m4,07814,516 28.1%   
Long term debt Rs m1,6714,189 39.9%   
Total assets Rs m12,63329,805 42.4%  
Interest coverage x1.03.5 29.7%   
Debt to equity ratio x0.40.3 142.0%  
Sales to assets ratio x0.30.5 62.2%   
Return on assets %3.48.9 38.6%  
Return on equity %0.111.8 1.0%  
Return on capital %7.717.5 43.8%  
Exports to sales %22.924.8 92.4%   
Imports to sales %14.33.7 382.6%   
Exports (fob) Rs m9643,956 24.4%   
Imports (cif) Rs m602596 100.9%   
Fx inflow Rs m9644,952 19.5%   
Fx outflow Rs m607697 87.1%   
Net fx Rs m3574,255 8.4%   
CASH FLOW
From Operations Rs m1,3452,786 48.3%  
From Investments Rs m-2,256-1,529 147.5%  
From Financial Activity Rs m-1,200-941 127.5%  
Net Cashflow Rs m-2,111316 -667.1%  

Share Holding

Indian Promoters % 4.5 61.4 7.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 1.4 12.7 10.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 22.1 425.8%  
Shareholders   20,807 46,261 45.0%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   J.B.CHEMICALS  SUVEN LIFE  CIPLA  CADILA HEALTHCARE  ALEMBIC LTD  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Firm; Software & FMCG Stocks Gain(Closing)

Indian share markets finished the trading session well above the dotted line, snapping a three-day falling streak amid firm Asian markets.

Related Views on News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS